Back to Journals » ClinicoEconomics and Outcomes Research » Health-related Outcomes and Economic Burden in Japan. Focus on: Inflammatory Bowel Disease, Multiple Sclerosis, and Depression
![](https://www.dovepress.com/cr_data/cache/journal_image/29/cope/thumb_100_1000_100.jpg)
ClinicoEconomics and Outcomes Research
ISSN: 1178-6981
- View all (882)
- Volume 16, 2024 (35)
- Volume 15, 2023 (67)
- Volume 14, 2022 (61)
- Volume 13, 2021 (90)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Journal Articles:
Health-related Outcomes and Economic Burden in Japan. Focus on: Inflammatory Bowel Disease, Multiple Sclerosis, and Depression
This Thematic Series contains articles covering a breadth of comorbidity types, from gastrointestinal to neurological to mental health domains using data collected from the National Health and Wellness Survey in Japan to assess the burden of inflammatory bowel disease, multiple sclerosis, and depression using a common methodology involving cases vs. controls and patient-reported outcome measures (PROMs). The database is a population-based, self-reported online survey recruiting respondents from opt-in online panels. The survey collects demographic information, health characteristics, and PROMs across respondents with a wide range of disease conditions.
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Thematic Series](assets/img/article_icons/thematic-series.png)
Health-related outcomes and economic burden in Japan: focus on inflammatory bowel disease, multiple sclerosis, and depression
Yamabe K
ClinicoEconomics and Outcomes Research 2018, 10:653-654
Published Date: 23 October 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Thematic Series](assets/img/article_icons/thematic-series.png)
Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries
Yamabe K, DiBonaventura MD, Pashos CL
ClinicoEconomics and Outcomes Research 2019, 11:61-71
Published Date: 7 January 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Thematic Series](assets/img/article_icons/thematic-series.png)
Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan
Yamabe K, Liebert R, Flores N, Pashos CL
ClinicoEconomics and Outcomes Research 2019, 11:221-232
Published Date: 12 March 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Thematic Series](assets/img/article_icons/thematic-series.png)
Health-related quality of life outcomes, economic burden, and associated costs among diagnosed and undiagnosed depression patients in Japan
Yamabe K, Liebert R, Flores N, Pashos CL
ClinicoEconomics and Outcomes Research 2019, 11:233-243
Published Date: 12 March 2019